Chemomab Therapeutics Ltd. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Chemomab Therapeutics Ltd. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2023.
  • Chemomab Therapeutics Ltd. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $0.000.
  • Chemomab Therapeutics Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.5M.
  • Chemomab Therapeutics Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$808K, a 101% decline from 2021.
  • Chemomab Therapeutics Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $61.1M, a 1186% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $0 -$47.8M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $47.8M +$47.3M +9460% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $500K -$27.3M -98.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $27.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.